A Phase II Trial of Neoadjuvant Albumin-Bound Paclitaxel plus Carboplatin Combined with Tislelizumab in Locally Advanced HNSCC: Efficacy and Biomarker Exploration

发表于 2026-7-6 15:48:08

期刊：Clinical Cancer Research

文献作者：Qianxia Li; Min Fu; Dong Kuang; Chu Pan; Yi Huang; Lanjun Cai; Jing Zhao; Ping Huang; Chao He; Kai Xu; Guoxian Long; Dongbo Liu; Lin Yang; Xiang Lu; Guangyuan Hu

出版日期：2026-1-16

DOI号：10.1158/1078-0432.ccr-25-2911

下载链接：https://aacrjournals.org/clincan ... 247/ccr-25-2911.pdf

文献链接：https://doi.org/10.1158/1078-0432.ccr-25-2911

当前文献来源于 American Association for Cancer Research (AACR)。

备注信息：

发表于 2026-7-6 15:48:09

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[AACR] A Phase II Trial of Neoadjuvant Albumin-Bound Paclitaxel plus Carboplatin Combined with Tislelizumab in Locally Advanced HNSCC: Efficacy and Biomarker Exploration

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[AACR] A Phase II Trial of Neoadjuvant Albumin-Bound Paclitaxel plus Carboplatin Combined with Tislelizumab in Locally Advanced HNSCC: Efficacy and Biomarker Exploration 一键复制

已采纳